Benedikt Kessler | |
|---|---|
 | |
| Academic background | |
| Education | B.A., Biochemistry Ph.D., Immunology |
| Alma mater | Swiss Federal Institute of Technology Ludwig Institute for Cancer Research |
| Academic work | |
| Institutions | University of Oxford |
Benedikt Kessler is a Swiss researcher and academic. He is Professor of Biochemistry and Mass Spectrometry at the Target Discovery Institute, University of Oxford.[1]
Kessler's research has been focused on ubiquitin and protease biology. Some of his work has dealt with defining the molecular signatures in human disease processes and accelerating target discovery in translational research.[2][3] He holds two patents.[4][5]
Kessler is a member of the British Mass Spectrometry Society, the British Society of Cell Biology and the American Association for Cancer Research.[6]
- ^ "Benedikt Kessler".
- ^ "Benedikt Kessler - Google Scholar".
- ^ Wang, E. W.; Kessler, B. M.; Borodovsky, A.; Cravatt, B. F.; Bogyo, M.; Ploegh, H. L.; Glas, R. (2000). "Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity". Proceedings of the National Academy of Sciences of the United States of America. 97 (18): 9990–9995. Bibcode:2000PNAS...97.9990W. doi:10.1073/pnas.180328897. PMC 27648. PMID 10954757.
- ^ "Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefore".
- ^ "Active Site Probes".
- ^ "Benedikt M Kessler".